Chadha Saahil, Sritharan Durga V, Hager Thomas, D'Souza Rahul, Aneja Sanjay
Department of Therapeutic Radiology, Yale School of Medicine, 330 Cedar St, New Haven, CT, 06519, USA.
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, 06510, USA.
Curr Oncol Rep. 2025 Jun 12. doi: 10.1007/s11912-025-01688-w.
This article explores the evolving role of artificial intelligence (AI) in neuro-oncology, highlighting its potential to enhance diagnostic accuracy, predict patient outcomes, optimize treatment planning, and streamline clinical workflows.
AI applications have led to significant advancements in automated tumor segmentation, molecular classification, risk stratification, treatment response evaluation, and computational pathology. AI-driven innovations have also accelerated drug discovery and leveraged natural language processing to generate structured clinical reports and extract actionable insights from unstructured data. AI has transformative potential in neuro-oncology; however, challenges like data quality, model generalizability, and clinical integration persist. Overcoming these barriers may involve new computational techniques and hardware efficiencies, as well as raising awareness, fostering interdisciplinary education, and expanding access to AI-driven tools.
本文探讨了人工智能(AI)在神经肿瘤学中不断演变的作用,强调了其在提高诊断准确性、预测患者预后、优化治疗计划以及简化临床工作流程方面的潜力。
人工智能应用在自动肿瘤分割、分子分类、风险分层、治疗反应评估和计算病理学方面取得了重大进展。人工智能驱动的创新还加速了药物研发,并利用自然语言处理生成结构化临床报告,从非结构化数据中提取可操作的见解。人工智能在神经肿瘤学中具有变革潜力;然而,数据质量、模型通用性和临床整合等挑战依然存在。克服这些障碍可能需要新的计算技术和硬件效率,以及提高认识、促进跨学科教育和扩大对人工智能驱动工具的使用。